Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Expenses (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Operating Expenses for 6 consecutive years, with $3.1 million as the latest value for Q4 2021.

  • Quarterly Operating Expenses rose 36.25% to $3.1 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Dec 2021, changed 0.03% year-over-year, with the annual reading at $5.8 million for FY2025, 46.72% down from the prior year.
  • Operating Expenses for Q4 2021 was $3.1 million at ENDRA Life Sciences, up from $2.7 million in the prior quarter.
  • The five-year high for Operating Expenses was $3.3 million in Q3 2020, with the low at $360697.0 in Q1 2017.
  • Average Operating Expenses over 5 years is $2.4 million, with a median of $2.6 million recorded in 2019.
  • The sharpest move saw Operating Expenses skyrocketed 688.42% in 2018, then dropped 27.99% in 2020.
  • Over 5 years, Operating Expenses stood at $2.3 million in 2017, then dropped by 12.93% to $2.0 million in 2018, then surged by 56.31% to $3.1 million in 2019, then decreased by 27.99% to $2.3 million in 2020, then skyrocketed by 36.25% to $3.1 million in 2021.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $3.1 million, $2.7 million, and $3.2 million for Q4 2021, Q3 2021, and Q2 2021 respectively.